Waverton Investment Management Ltd Q4 2022 vs. Q1 2023: Investments in Technology and Healthcare Rise

Waverton Investment Management Ltd, a leading UK-based investment management firm, has disclosed its Q4 2022 and Q1 2023 13F holdings comparison highlighting the changes in its portfolio. The data shows that the company has increased its investments in the technology and healthcare sectors in Q1 2023.

The company has reduced its stake in many companies in the finance and energy sectors. For instance, Waverton Investment Management Ltd sold its entire holding in Linde Plc Com, a leading industrial gas supplier, and increased its stake in Microsoft Corporation by 734,111 shares in Q4 2022 compared to the Q1 2023. This saw the value of their Microsoft investment increase from $176,055,000 to $208,052,000, representing a growth of 18.2%.

Similarly, the company sold all its shares in the energy giant, Exxon Mobil Corporation Com, and reduced its stake in Union Pacific Corporation Com by more than half. These changes indicate a shift in the company's investment strategy towards technology and healthcare sectors, a trend that many investment management firms are adopting.

Investments in Technology

The technology sector witnessed the highest growth in investments by Waverton Investment Management Ltd, with the company increasing its holding in many tech companies such as Alphabet Inc and Apple Inc. The firm increased its investment in Alphabet Inc Class A shares by 1.9%, raising the value of its portfolio from $112,750,000 in Q4 2022 to $133,864,000 in Q1 2023. The company also increased its stake in Apple Inc Com by 2,520 shares, representing a growth of 0.8%.

Waverton Investment Management Ltd also invested heavily in Advanced Micro Devices, increasing their stake by 31,275 shares to a total of 1,340,694 shares. This represents a growth of 55% and indicates the firm's confidence in the semiconductor industry's growth potential.

Investments in Healthcare

Waverton Investment Management Ltd had a strong position in the healthcare sector, with holdings in healthcare providers such as United Health Group Com, HCA Healthcare Inc, and Bristol-Myers Squibb Co. The company increased its stake in United Health Group Com by 189,684 shares, representing a growth of 385.5%, and in HCA Healthcare Inc by 273%, raising their stake from 67,480 shares in Q4 2022 to 251,200 shares in Q1 2023.

Additionally, the company increased its holding in Bristol-Myers Squibb Co by 65,494 shares, representing a growth of 11.8%. This indicates the firm's confidence in the healthcare sector, which has seen significant growth in recent years due to an aging population and increasing demand for healthcare services.

Conclusion

Waverton Investment Management Ltd's Q4 2022 vs. Q1 2023 13F holdings comparison indicates an increase in the company's investments in the technology and healthcare sectors. The company reduced its stake in many companies in the finance and energy sectors, indicating a shift in investment strategy. This trend is in line with many investment management firms' strategy, which are allocating more funds to the technology and healthcare sectors due to their growth potential.